U.S. Biotech Stock News

BlackRock stock has delivered a strong 54.0% return over the past three years, yet the current checks suggest it may now be closer to fairly valued on intrinsic estimates while screening as expensive on earnings multiples. A 54.0% gain over three years sets a high bar for new buyers, since a lot of good news can already be reflected in the price. Recent headlines around record assets under management, ETF inflows and expansion into areas like digital assets may support confidence in future...

New tariffs from President Donald Trump are shaking up trade relationships with 60 U.S. partners, and that puts the spotlight firmly on companies tied to American infrastructure and construction. Higher import costs, possible retaliation from countries like Australia, and pressure on global supply chains could all shift demand toward businesses with stronger domestic footprints. For investors, this screen of US Infrastructure and Construction Companies is a way to focus on stocks that are...

Dynex Capital stock has delivered a 49.1% total return over the past three years. However, the current valuation picture is more mixed, with recent share price weakness and only a middling overall value score. Over the last 3 years Dynex Capital has returned 49.1%, which puts recent short-term share price declines into a longer-term positive context for existing holders. The recent earnings strength can support the case for higher justified valuation multiples. At the same time, the inherent...

L3Harris Technologies (NYSE:LHX) has signed long-term framework agreements with the Department of War and Lockheed Martin. The contracts cover a major ramp up in propulsion system production for the PAC-3 Missile Segment Enhancement and THAAD programs. The agreements run for seven years and represent the largest propulsion awards for PAC-3 and THAAD in L3Harris history. L3Harris Technologies enters these contracts with its shares trading at $303.48 and a 1 year return of 14.4%. The stock is...

With the 30 year US Treasury yield holding above 5% and government bonds offering richer income, investors are rethinking how they balance risk and reward across the stock market. Higher real yields can pressure some sectors, yet they may also reshape earnings power for certain financial groups that live and breathe interest margins and investment income. This article looks at how that backdrop connects to large banks and insurers in our Financial Sector Stocks screener. You will see three...

HCA Healthcare, Inc. ( NYSE:HCA ) investors will be delighted, with the company turning in some strong numbers with its...

German American Bancorp reported record net income for the second quarter of 2026. The results set a new earnings benchmark for the company. Management highlighted net interest margin expansion, loan growth, and controlled expenses as key drivers. German American Bancorp, traded as NasdaqGS:GABC, is drawing fresh attention after posting the highest quarterly earnings in its history. The stock last closed at $48.83 and has risen 25.6% year to date and 25.1% over the past year, which puts...

Agilent Technologies (A) stock is in focus after the company received U.S. Food and Drug Administration approval for its PD-L1 IHC 28-8 pharmDx assay, a companion diagnostic for several gastrointestinal cancers. See our latest analysis for Agilent Technologies. Against this FDA approval backdrop, Agilent Technologies’ share price of $137.89 sits after a 7 day share price return of 5.86% and a 90 day share price return of 20.04%. The 1 year total shareholder return of 16.28% points to momentum...

Happen stock has delivered a strong 123.5% return over the past three years. However, the latest valuation checks and recent share price pullback leave the current pricing looking less straightforward than a simple momentum story. Over the past three years, Happen has returned 123.5%, which puts recent short term weakness into context for longer term holders. The recent rebrand to Happen Bank and Nasdaq listing may support higher growth expectations. At the same time, any disappointment in...

Penumbra (PEN) is back on investor radar after Novant Health reported successful clinical use of its newly cleared THUNDERBOLT computer assisted vacuum thrombectomy system for ischemic stroke treatment in North Carolina. See our latest analysis for Penumbra. Penumbra's recent THUNDERBOLT update comes as the stock trades at US$319.49, with a 1 year total shareholder return of 38.81%, while the 3 year total shareholder return of 5.32% and 5 year total shareholder return of 20.43% point to more...

Shareholders of Booz Allen Hamilton Holding Corporation ( NYSE:BAH ) will be pleased this week, given that the stock...

With semiconductor and AI stocks under pressure after a sharp global selloff, some investors are taking a fresh look at dividend payers outside the tech spotlight. The news-driven volatility around Nvidia and other chipmakers has not hit every corner of the market in the same way. Some companies with a focus on dividend stability and lower risk profiles may see sentiment shift in their favor, while others could still face indirect headwinds. This article walks through 3 stocks from a Non-Tech...

AI is no longer just about headline growth stories. As cheaper models and rising infrastructure costs reshape where profits may sit, the focus is shifting toward companies that help cut the AI bill rather than inflate it. This article looks at how recent news on open-weight models, hyperscaler spending plans, and geopolitical pressures is influencing cost-focused AI exposure. It will walk through 3 stocks from the AI Cost-Optimization Beneficiaries screener that appear well aligned with the...

Education stocks sit at the crossroad of policy and profit, and the new Trump administration student visa rule is a powerful reminder of how fast that connection can change. A potential one third drop in international student enrollment and a hit of up to US$400b to annual economic output could reshape demand, funding and growth plans across the sector. For investors, that creates both risk and opportunity. This article looks at three education related stocks exposed to this news and explains...

Apollo-managed funds recently completed the acquisitions of Emerald Holding and Questex, and separately committed US$1.50 billion to Keppel Ltd.’s Keppel Offshore Fund to support offshore energy assets in Southeast Asia. Together, these moves broaden Apollo’s exposure to B2B events and infrastructure-related energy assets, underpinned by a newly appointed leadership team at the combined Emerald-Questex platform. We’ll now examine how Apollo’s large commitment to Keppel’s offshore energy fund...

Nucor reported a second consecutive quarterly record for steel mill shipments in Q2. The company also posted Q2 earnings and revenue that were well ahead of prior expectations. Recent results highlight strong underlying demand and supportive sector and policy conditions for Nucor. Nucor, traded as NYSE:NUE, is coming off a strong run, with the stock up 7.4% over the past week and 46.3% year to date. The current share price of $247.86 sits against a 1 year return of 73.8%, which puts recent...

In the last week, the United States market has been flat, but over the past 12 months, it has experienced a 15% rise with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are potentially undervalued with insider buying can be a strategic approach for investors looking to capitalize on growth opportunities within small-cap companies.

Over the last seven days, the United States market has remained flat, yet it has experienced a 15% rise over the past year with earnings projected to grow by 17% annually. In this environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors looking to capitalize on undervalued assets.

Over the last 7 days, the United States market has remained flat, yet it has seen a 15% increase over the past year with earnings expected to grow by 17% annually in the coming years. In this context of steady market performance and promising growth prospects, companies with high insider ownership can be particularly appealing as they often align management's interests with those of shareholders while potentially achieving significant earnings growth.

In the last week, the market has been flat, but it is up 15% over the past year, with earnings forecast to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer surprising value when built on solid financials. We've selected three examples of penny stocks that combine balance sheet strength with potential for outsized gains, giving investors the chance to discover hidden value in quality companies.

The market has been flat in the last week but has shown a 15% increase over the past year, with earnings projected to grow by 17% annually. In such an environment, dividend stocks like CompX International can offer investors a stable income stream and potential for growth, making them worthwhile considerations.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

With the business potentially at an important milestone, we thought we'd take a closer look at RenovoRx, Inc.'s...

First Citizens BancShares (FCNC.A) is in focus after releasing second quarter 2026 results, along with fresh earnings guidance and an updated capital return picture that includes buybacks and a reaffirmed dividend. See our latest analysis for First Citizens BancShares. At a share price of $2,137.36, First Citizens BancShares has seen a 7.76% 90 day share price return, while the 1 year total shareholder return of 4.7% sits against a much stronger 3 year total shareholder return of 51.06%. This...